Inflammatory markers improve research models for mild frailty classification
Published in Artificial Intelligence, Immunology, Journals.
Published October 29, 2026.
Blood inflammatory markers may add information to research models that classify mild frailty. A study published in BMC Geriatrics on October 28 examined participants in the GAINS cohort using clinical assessments and a panel of 27 serum inflammatory markers.
The initial analysis included 165 participants, of whom 31 met the study’s frailty definition of a Clinical Frailty Scale score of at least four. Those classified as frail had a median score of four. Higher interleukin-2 levels remained associated with frailty after adjustment for age, gender, cognitive assessment and nutritional status.
Machine-learning analyses found that inflammatory markers improved classification compared with clinical variables alone. An additional analysis incorporated follow-up information in a group of 189 participants.
The findings support further investigation of inflammation in mild frailty. They show association and classification performance within this study, rather than proof that IL-2 causes frailty or that changing it improves health. Independent validation would be needed before using such a model as a clinical test.
Source: Akie et al., BMC Geriatrics. Published October 28, 2026. DOI: 10.1186/s12877-026-08497-1.